Capital
New York and Missouri’s Contrasting Cannabis Market Progress in 2023
NEW YORK- In a striking contrast of cannabis market development, New York and Missouri have reported significantly differing sales figures in 2023. New York's licensed cannabis ...
Cybin Inc. Secures $30 Million in Funding to Advance Psychedelic Treatment Research
NEW YORK- Toronto-based Cybin Inc., a clinical-stage biopharmaceutical company, has successfully completed a significant funding round, bolstering its commitment to revolutionize mental healthcare through the development ...
Silo Pharma Secures Exclusive License for MedSpray’s Intranasal Technology for SPC-15 Drug Delivery
NERW YORK – Silo Pharma, Inc. a biopharmaceutical company at the forefront of merging traditional therapeutics with psychedelic research, announced today its new exclusive licensing agreement ...
MariMed Inc. Secures $58.7 Million Loan from Needham Bank to Bolster Operations and Reduce Debt
LOS ANGELES- MariMed Inc. a player in the cannabis industry, has recently finalized a substantial financial deal with Needham Bank, a community bank based in Massachusetts. ...
AYR Wellness Financial Performance in Q3 2023
NEW YORK– AYR Wellness Inc. U.S. multi-state cannabis operator, has disclosed its financial results for the third quarter ending September 30, 2023. The company reported a ...
Florida High Court Favoring Voter Decision on Cannabis Legalization
NEW YORK– In a significant development for cannabis legalization advocates in Florida, the state's Supreme Court appears inclined to permit a proposal for adult-use cannabis legalization ...
Cresco Labs Delivers Q3 2023 Results, Execution of Core Market Strategy
NEW YORK– Cresco Labs Inc., a player in the cannabis industry, has unveiled its third-quarter financial and operating results for the period ending September 30, 2023. ...
Cybin Inc. Secures $30 Million in Funding, Strengthening Pathway for Psychedelic-Based Mental Health Treatments
LOS ANGELES— Cybin Inc., a prominent clinical-stage biopharmaceutical company, has successfully closed its substantial underwritten offering, amassing US$30 million to propel its mission of transforming mental ...
Clearmind Medicine Partners with Johns Hopkins and Yale for Pioneering Alcohol Use Disorder Clinical Trial
Tel Aviv— Clearmind Medicine Inc., a trailblazer in psychedelic drug development, has announced a significant milestone in its journey to address Alcohol Use Disorder (AUD). The ...
Glass House Brands Inc. Record in Q3 2023
LOS ANGELES- Glass House Brands Inc., a player in the cannabis industry, announced its financial achievements for the third quarter ending September 30, 2023, marking a ...
Tilt Holdings Inc. Reports Revenue Growth in Q3 Amidst Strategic Refinements
LOS ANGELES- Tilt Holdings Inc. a diversified cannabis industry player, has reported a significant increase in revenue for the third quarter ending September 30, as the ...
Curaleaf Announces Third Quarter 2023
LOS ANGELES- Curaleaf Holdings, Inc., a international cannabis consumer products company, has released its financial and operational results for the third quarter ending September 30, 2023. ...
